Shortages, substitutes and uncertainty: the new reality of drugs supplies

Yaroslav Astakhov/Shutterstock.com The reliable supply of drugs is fundamental to any healthcare system, yet shortages remain a persistent problem. Disruptions arise from a range of causes: manufacturing failures, fluctuating demand, regulatory changes and wars. Around 60% of drug shortages are linked to manufacturing bottlenecks, while insufficient reserves of both finished products and raw ingredients continue […]

Headspace: can our brains get full?

Maciej Bledowski/Shutterstock.com My husband was recently describing something that happened on a past holiday. It wasn’t a significant event, but it sounded pleasant. I, however, had no recollection of what he was telling me. He couldn’t quite believe it. We know that “recollections may differ”, but how can it be so different? And why do […]

The Russian resistance no one is talking about

You could be forgiven for thinking everyone in Russia either supports the war in Ukraine or is too scared to do anything about it. A dominant narrative is that Russian civil society is passive, complicit or has been quashed to the point of being neutralised. Some elements of this may be true. Following the full-scale […]

How to Enter the Art World by Hettie Judah offers a smørgasbord of sage advice

“Most artists work alone, with little to steer them save crummy ‘how to’ guides.” So writes author and curator Hettie Judah in her new book, How to Enter the Art World. At first glance, the book’s presentation might mislead the reader into believing it to be another giant crumb from the loaf of bad guidance. […]

Codeine: why one person’s painkiller can be another person’s problem

Jack_the_sparow/Shutterstock For a medicine so commonly found in bathroom cabinets and high street pharmacies, codeine has a surprisingly complicated story. It sits at the intersection of pain relief, genetics, public health and regulation. As the UK continues to tighten rules around opioid use, codeine offers a useful case study in how a drug can be […]

Palantir and the NHS – 10 things you need to know

Who has access? DC Studio/Shutterstock.com Palantir, a US data analytics company backed in its early years by In-Q-Tel, now plays a central role in the NHS’s £330 million Federated Data Platform. Supporters say it could improve planning and efficiency, while critics have raised questions about governance, transparency and trust. Here’s what you need to know. […]